申请人:Exelixis, Inc.
公开号:US20140228401A1
公开(公告)日:2014-08-14
This invention is directed to the treatment of osteoporosis using N-(4-[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide.
本发明涉及使用N-(4-[6,7-双甲氧基喹啉-4-基]氧基}苯基)-N'-(4-氟苯基)环丙烷-1,1-二羧酰胺治疗骨质疏松症。